← Back to Search

Dietary Supplement

Vitamin D3 + Omega-3 Fatty Acids for Infections

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is investigating whether taking daily dietary supplements of vitamin D3 or omega-3 fatty acids reduces the risk of developing cancer, heart disease, and stroke.

Who is the study for?
This trial is for participants already enrolled in the VITAL study (NCT 01169259), which includes U.S. men and women without a prior history of cancer, heart disease, or stroke.
What is being tested?
The study tests if daily supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (1 gram fish oil) can reduce the risk of infections and affect hCAP18 levels in blood.
What are the potential side effects?
Potential side effects may include mild digestive discomfort from fish oil and possible high calcium levels or kidney stones from vitamin D3, though individual reactions vary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: vitamin D placebo + fish oilActive Control2 Interventions
vitamin D placebo + Omacor
Group II: vitamin D + fish oilActive Control2 Interventions
vitamin D3 + Omacor
Group III: vitamin D + fish oil placeboActive Control2 Interventions
vitamin D3 + fish oil placebo
Group IV: vitamin D placebo + fish oil placeboPlacebo Group2 Interventions
vitamin D placebo + fish oil placebo

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,653 Previous Clinical Trials
11,465,161 Total Patients Enrolled
25 Trials studying Infections
24,582 Patients Enrolled for Infections

Media Library

Fish Oil (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT01758081 — N/A
Infections Research Study Groups: vitamin D placebo + fish oil, vitamin D + fish oil, vitamin D + fish oil placebo, vitamin D placebo + fish oil placebo
Infections Clinical Trial 2023: Fish Oil Highlights & Side Effects. Trial Name: NCT01758081 — N/A
Fish Oil (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01758081 — N/A
~299 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top